Collegium Pharma (NASDAQ: COLL) reported Q2 EPS of ($0.14), $0.05 better than the analyst estimate of ($0.19). Revenue for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Earnings

Collegium Reports Second Quarter 2019 Financial ResultsAugust 7, 2019 4:02 PM